Lesions predictive for prostate cancer in a screened population: First and second screening round findings

Prostate

Volumn 61, Issue 3, 2004, Pages 260-266

  Postma, Renske ^a   Roobol, Monique ^a   Schröder, Fritz H ^a   Van Der Kwast, Theodorus H ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

Author keywords

Lesions suspicious for prostate cancer; Needle biopsy; Prostate cancer; Prostatic intraepithelial neoplasia; Screening

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREDICTION AND FORECASTING; PREVALENCE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; SCREENING;

AGED; BIOPSY, NEEDLE; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS;

EID: 5344266808     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.20105     Document Type: Article

References (28)

1. Lefkowitz GK, Taneja SS, Brown J, Melamed J, Lepor H. Followup interval prostate biopsy 3 years after diagnosis of high grade prostatic intraepithelial neoplasia is associated with high likelihood of prostate cancer, independent of change in prostate specific antigen levels. J Urol 2002;168(4 Pt 1):1415-1418.
2. Iczkowski KA, Bassler TJ, Schwob VS, Bassler IC, Kunnel BS, Orozco RE, Bostwick DG. Diagnosis of suspicious for malignancy in prostate biopsies: Predictive value for cancer. Urology 1998;51(5):749-757; discussion 757-758.
3. Yang XJ, Wu CL, Woda BA, Dresser K, Tretiakova M, Fanger GR, Jiang Z. Expression of alpha-methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol 2002;26(7):921-925.
4. Iczkowski KA, MacLennan GT, Bostwick DG. Atypical small acinar proliferation suspicious for malignancy in prostate needle biopsies: Clinical significance in 33 cases. Am J Surg Pathol 1997;21(12):1489-1495.
5. Cheville JC, Reznicek MJ, Bostwick DG. The focus of atypical glands, suspicious for malignancy in prostatic needle biopsy specimens: Incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice. Am J Clin Pathol 1997;108(6):633-640.
6. Bostwick DG, Qian J, Frankel K. The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies. J Urol 1995;154(5):1791-1794.
7. Bostwick DG, Algaba F, Amin MB, Ayala A, Eble J, Goldstein N, Helpap B, Humphrey P, Grignon D, Jones EC, McNeal J, Montironi R, Qian J, Ro J, Sringley J, Teru B, Troncoso P, True L, Wheeler T, Young RH. Consensus statement on terminology: Recommendation to use atypical adenomatous hyperplasia in place of adenosis of the prostate. Am J Surg Pathol 1994;18(10): 1069-1070.
8. Hoedemaeker RF, Kranse R, Rietbergen JB, Kruger AE, Schroder FH, van der Kwast TH. Evaluation of prostate needle biopsies in a population-based screening study: The impact of borderline lesions. Cancer 1999;85(1):145-152.
9. DeMarzo AM, Nelson WG, Isaacs WB, Epstein JI. Pathological and molecular aspects of prostate cancer. Lancet 2003;361(9361): 955-964.
10. Kronz JD, Allan CH, Shaikh AA, Epstein JI. Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy: Data on men with more than one follow-up biopsy. Am J Surg Pathol 2001;25(8):1079-1085.
11. Zackrisson B GA, Lilja H, Lodding P, Pihl CG, Hugosson J. Follow up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening. Urology 2003;43:327-332.
12. O'Dowd GJ, Miller MC, Orozco R, Veltri RW. Analysis of repeated biopsy results within 1 year after a noncancer diagnosis. Urology 2000;55(4):553-559.
13. Park S, Shinohara K, Grossfeld GD, Carroll PR. Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy. J Urol 2001;165(5):1409-1414.
14. Hoedemaeker RF, van der Kwast TH, Boer R, de Koning HJ, Roobol M, Vis AN, Schroder FH. Pathologic features of prostate cancer found at population-based screening with a four-year interval. J Natl Cancer Inst 2001;93(15):1153-1158.
15. Postma R, Roobol M, Schroder FH, Van Der Kwast TH. Potentially advanced malignancies detected by screening for prostate carcinoma after an interval of 4 years. Cancer 2004; 100(5):968-975.
16. Allam CK, Bostwick DG, Hayes JA, Upton MP, Wade GG, Domanowski GF, Klein MA, Boling EA, Stilmant MM. Interobserver variability in the diagnosis of high-grade prostatic intraepithelial neoplasia and adenocarcinoma. Mod Pathol 1996;9(7):742-751.
17. Sakr WA, Billis A, Ekman P, Wilt T, Bostwick DG. Epidemiology of high-grade prostatic intraepithelial neoplasia. Scand J Urol Nephrol Suppl 2000;205:11-18.
18. Sakr WA, Grignon DJ, Crissman JD, Heilbrun LK, Cassin BJ, Pontes JJ, Haas GP. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: An autopsy study of 249 cases. In Vivo 1994;8(3): 439-443.
19. Fowler JE Jr., Bigler SA, Miles D, Yalkut DA. Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer. J Urol 2000;163(3):813-818.
20. Allen EA, Kahane H, Epstein JI. Repeat biopsy strategies for men with atypical diagnoses on initial prostate needle biopsy. Urology 1998;52(5):803-807.
21. Hoedemaeker RF, Rietbergen JB, Kranse R, Schroder FH, van der Kwast TH. Histopathological prostate cancer characteristics at radical prostatectomy after population based screening. J Urol 2000;164(2):411-415.
22. Stricker HJ, Ruddock LJ, Wan J, Belville WD. Detection of non-palpable prostate cancer. A mathematical and laboratory model. Br J Urol 1993;71(1):43-46.
23. Prange W, Erbersdobler A, Hammerer P, Graefen M, Hautmann SH, Hautmann RE, Huland H, Henke RP. High-grade prostatic intraepithelial neoplasia in cystoprostatectomy specimens. Eur Urol 2001;39(Suppl 4):30-31.
24. Mian BM, Naya Y, Okihara K, Vakar-Lopez F, Troncoso P, Babaian RJ. Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy. Urology 2002;60(5):836-840.
25. Djavan B, Zlotta A, Remzi M, Ghawidel K, Basharkhah A, Schulman CC, Marberger M. Optimal predictors of prostate cancer on repeat prostate biopsy: A prospective study of 1,051 men. J Urol 2000;163(4):1144-1148; discussion 1148-1149.
26. Ukimura O, Durrani O, Babaian RJ. Role of PSA and its indices in determining the need for repeat prostate biopsies. Urology 1997; 50(1):66-72.
27. Fleshner NE, O'Sullivan M, Fair WR. Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate. J Urol 1997;158(2):505-508; discussion 508-509.
28. Kwast van der TH, Roobol MJ, Wildhagen MF, Martikainen PM, Maatanen L, Pihl CG, Santonja C, Bubendorf L, Neetens I, di Iollo S, Hoedemaeker RF. Consistency of prostate cancer grading results in screened populations across Europe. BJU Int 2003; 92(s2 page):88-91.